Perhaps, FDA will approve Copaxone on 1/12/2011? That would be fantastic. If that happens, i suspect MNTA stock will soar to 30, and then head back to 12. :(
Assuming MNTA gets final approval of the Copaxone ANDA in Q1 2011, what probability would you assign (%) that MNTA/NVS will launch at risk? TIA for your insight/opinion.